Clinical Trials Directory

Trials / Completed

CompletedNCT04847817

Important Data on COVID-19 Profile in Africa

Status
Completed
Phase
Study type
Observational
Enrollment
574 (actual)
Sponsor
Centre de Recherche Médicale de Lambaréné · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

The purpose of this study is to Understand the natural history of Coronavirus 2019 (COVID-19) infection to better define the period of infectiousness and transmissibility and to establish biobanks of COVID-19 blood and mucosal samples.

Detailed description

In this study ,the participants will be enrolled sequentially in the COVID-19 care referral centers. The infected hospitalized patient will be identified by the physicians in hospital. After the patient has given his/her informed consent the permission will be sought from him to approach his household contacts. The household contacts will be screened, and included in the study. Patients hospitalized and positive for COVID-19 by PCR and their household contacts of all ages and gender (40% minimum of female), will be enrolled upon receipt of written informed consent.

Conditions

Timeline

Start date
2020-08-01
Primary completion
2021-12-31
Completion
2022-03-01
First posted
2021-04-19
Last updated
2022-07-19

Locations

2 sites across 1 country: Gabon

Source: ClinicalTrials.gov record NCT04847817. Inclusion in this directory is not an endorsement.